The Wall Street Journal reports on increasingly aggressive efforts by attorneys general in several U.S. states to pursue legal actions against drug companies for deceptive marketing.
Using consumer protection laws as a basis, state officials have gone after some major pharmaceutical companies, including GlaxoSmithKline, Sanofi SA, Bristol-Myers Squibb Co and Teva Pharmaceutical Industries Ltd.
The story notes that potential payouts are high. Last year, for example, Johnson & Johnson agreed to ...
continue reading...
An investing blog on CNBC.com warns potential investors about health care giant Johnson & Johnson.
A story in the Washington Post says that several Johnson & Johnson shareholders spoke of their dissatisfaction with the company during their annual meeting recently. Their complaints focused on a long string of product recalls, ethical lapses and excessive executive pay.
An American plaintiff awarded $11.1 million in court because of her injuries from a vaginal mesh implant is lending her support to women seeking similar legal redress in Scotland and the U.K., according to a story in the Scots paper Daily Record.
A story in the Daily Record out of Scotland deals with the plight of Scots women injured after receiving vaginal mesh implants. Hundreds may be “suffering horrendous health problems” from the devices, which are implanted to treat urinary incontinence and pelvic organ prolapse.
Johnson & Johnson, the worlds’ largest maker of health care products, has announced that its first-quarter profits were down, but that its earnings nevertheless beat analysts’ estimates.
